Xiamen Amoytop Biotech Co., Ltd. (688278.SS) SHH

Currency In CNY

AD

Valuation

Market Cap34.05B
Enterprise Value33.68B
P/E Ratio23.53
PEG Ratio1.59
Price/Sales Ratio6.24
Price/Book Ratio6.56
Enterprise/Revenue6.04
Enterprise/EBITDA19.17

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.27
Operating Margin0.32
AD

Management Effectiveness

Return On Assets0.23
Return On Equity0.32

Income Statement

Revenue3.7B
Revenue/Share9.36
Gross Profit3.44B
EBITDA1.24B
Net Income1.03B
Diluted EPS2.52

Balance Sheet

Total Cash1.09B
Total Cash/Share2.66
Total Debt186.88M
Total Debt/Equity0.05
Current Ratio4.79
Book Value Per Share8.89

Price History

52-Week Change-34.8
52-Week High90.95
52-Week Low50
Moving Average 50 Days56.73
Moving Average 200 Days68.27

Statistics

Average Volume3.88M
Shares Outstanding408.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield1.06
Payout Ratio0.25
Last Split FactorN/A
Last Split DateN/A
AD